Global Information
회사소개 | 문의 | 비교리스트

약독생수두백신 시장(2020년)

Global Varicella Attenuated Live Vaccine Market Research Report 2020

리서치사 QYResearch
발행일 2020년 11월 상품 코드 968200
페이지 정보 영문
가격
US $ 2,900 ₩ 3,241,000 PDF (Single User License)
US $ 4,350 ₩ 4,861,000 PDF (Multi User License)
US $ 5,800 ₩ 6,482,000 PDF (Enterprise Wide License)


약독생수두백신 시장(2020년) Global Varicella Attenuated Live Vaccine Market Research Report 2020
발행일 : 2020년 11월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 약독생수두백신 시장 규모는 2019년에 23억 7,715만 달러를 기록했습니다. 이 시장은 2020-2026년 4.25%의 CAGR로 성장할 전망이며, 2026년에는 31억 5, 246만 달러에 달할 것으로 예측되고 있습니다.

세계의 약독생수두백신 시장에 대해 조사했으며, 시장 규모 및 예측, 동향, 기회, 성장요인 및 과제, 유형·용도·제조업체·지역별 시장 분석, 경쟁 구도, 주요 기업의 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 시장 개요

  • 제품 개요와 범위
  • 유형별 부문
    • 판매 성장률 비교(2020-2026)
    • 단일가백신
    • 혼합백신
  • 용도별 부문
    • 판매 비교(2020-2026)
    • 어린이
    • 성인
  • 시장 규모 추산·예측
    • 매출(2015-2026)
    • 판매(2015-2026)
    • 지역별 시장 규모 : 2020 vs 2026

제2장 시장 경쟁 : 제조업체별

  • 판매 시장 점유율(2018-2019)
  • 매출 시장 점유율(2018-2019)
  • 평균 가격(2018-2019)
  • 제조업체 본부
  • 시장의 경쟁 상황과 동향

제3장 시장 시나리오 : 지역별(2015-2020)

  • 판매
  • 매출
  • 북미
    • 판매
    • 매출
    • 미국
    • 캐나다
  • 유럽
    • 판매
    • 매출
    • 독일
    • 그리스
    • 이탈리아
    • 스페인
  • 아시아태평양
    • 판매
    • 매출
    • 중국
    • 일본
    • 한국
    • 동남아시아
  • 라틴아메리카
    • 판매
    • 매출
    • 멕시코
    • 브라질
    • 아르헨티나
  • 중동·아프리카
    • 판매
    • 매출
    • 중동
    • 아프리카

제4장 시장 분석 : 유형별(2015-2020)

  • 판매 시장 점유율
  • 매출 시장 점유율
  • 가격

제5장 시장 분석 : 용도별

  • 판매 시장 점유율(2015-2020)
  • 판매 성장 예측(2016-2020)

제6장 기업 개요

  • Merck
  • BCHT
  • Shanghai Institute
  • GSK
  • Keygen
  • Green Cross
  • Biken
  • Shanghai Rongsheng Biotech
  • Changsheng

제7장 제조 비용 분석

  • 주요 원재료 분석
  • 제조 프로세스 분석
  • 산업 체인 분석

제8장 마케팅 채널과 유통업체

  • 마케팅 채널
  • 유통업체

제9장 시장 역학

  • 시장 동향
  • 기회와 성장요인
  • 과제
  • Porter의 산업 분석

제10장 세계 시장 예측

  • 유형별 시장 추산·예측
  • 용도별 시장 추산·예측
  • 지역별 시장 추산·예측

제11장 조사 결과·결론

제12장 조사 방법과 정보원

KSA 20.11.17

List of Tables and Figures

  • Table 1. Global Varicella Attenuated Live Vaccine Sales (K Doses) Growth Rate Comparison by Type (2020-2026)
  • Table 2. Global Varicella Attenuated Live Vaccine Sales (K Doses) Comparison by Application (2020-2026)
  • Table 3. Global Varicella Attenuated Live Vaccine Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
  • Table 4. Key Manufacturers Varicella Attenuated Live Vaccine Covered in This Study
  • Table 5. Global Varicella Attenuated Live Vaccine Sales (K Doses) of Key Manufacturers (2018-2019)
  • Table 6. Global Varicella Attenuated Live Vaccine Sales Market Share by Manufacturers (2018-2019)
  • Table 7. Global Varicella Attenuated Live Vaccine Revenue (US$ Million) by Manufacturers (2018-2019)
  • Table 8. Global Varicella Attenuated Live Vaccine Revenue Share by Manufacturers (2018-2019)
  • Table 9. Global Market Varicella Attenuated Live Vaccine Average Price (USD/Dose) of Key Manufacturers (2018-2019)
  • Table 10. Manufacturers Varicella Attenuated Live Vaccine Headquarters
  • Table 11. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 12. Global Varicella Attenuated Live Vaccine Sales by Region (2015-2020) & (K Doses)
  • Table 13. Global Varicella Attenuated Live Vaccine Sales Market Share by Region (2015-2020)
  • Table 14. Global Varicella Attenuated Live Vaccine Revenue by Region (2015-2020) & (US$ Million)
  • Table 15. Global Varicella Attenuated Live Vaccine Revenue Market Share by Region (2015-2020)
  • Table 16. North America Varicella Attenuated Live Vaccine Sales by Country (2015-2020) & (K Doses)
  • Table 17. North America Varicella Attenuated Live Vaccine Sales Market Share by Country (2015-2020)
  • Table 18. North America Varicella Attenuated Live Vaccine Revenue by Country (2015-2020) & (US$ Million)
  • Table 19. North America Varicella Attenuated Live Vaccine Revenue Market Share by Country (2015-2020)
  • Table 20. Europe Varicella Attenuated Live Vaccine Sales by Country (2015-2020) & (K Doses)
  • Table 21. Europe Varicella Attenuated Live Vaccine Sales Market Share by Country (2015-2020)
  • Table 22. Europe Varicella Attenuated Live Vaccine Revenue by Country (2015-2020) & (US$ Million)
  • Table 23. Europe Varicella Attenuated Live Vaccine Revenue Market Share by Country (2015-2020)
  • Table 24. Asia Pacific Varicella Attenuated Live Vaccine Sales by Region (2015-2020) & (K Doses)
  • Table 25. Asia Pacific Varicella Attenuated Live Vaccine Sales Market Share by Region (2015-2020)
  • Table 26. Asia Pacific Varicella Attenuated Live Vaccine Revenue by Region (2015-2020) & (US$ Million)
  • Table 27. Asia Pacific Varicella Attenuated Live Vaccine Revenue Market Share by Region (2015-2020)
  • Table 28. Latin America Varicella Attenuated Live Vaccine Sales by Country (2015-2020) & (K Doses)
  • Table 29. Latin America Varicella Attenuated Live Vaccine Sales Market Share by Country (2015-2020)
  • Table 30. Latin America Varicella Attenuated Live Vaccine Revenue by Country (2015-2020) & (US$ Million)
  • Table 31. Latin America Varicella Attenuated Live Vaccine Revenue Market Share by Country (2015-2020)
  • Table 32. Middle East and Africa Varicella Attenuated Live Vaccine Sales by Country (2015-2020) & (K Doses)
  • Table 33. Middle East and Africa Varicella Attenuated Live Vaccine Sales Market Share by Country (2015-2020)
  • Table 34. Middle East and Africa Varicella Attenuated Live Vaccine Revenue by Country (2015-2020) & (US$ Million)
  • Table 35. Middle East and Africa Varicella Attenuated Live Vaccine Revenue Market Share by Country (2015-2020)
  • Table 36. Global Varicella Attenuated Live Vaccine Sales (K Doses) by Type (2015-2020)
  • Table 37. Global Varicella Attenuated Live Vaccine Sales Market Share by Type (2015-2020)
  • Table 38. Global Varicella Attenuated Live Vaccine Revenue (US$ Million) by Type (2015-2020)
  • Table 39. Global Varicella Attenuated Live Vaccine Revenue Share by Type (2015-2020)
  • Table 40. Global Varicella Attenuated Live Vaccine Price (USD/Dose) by Type (2015-2020)
  • Table 41. Global Varicella Attenuated Live Vaccine Sales (K Doses) by Application (2015-2020)
  • Table 42. Global Varicella Attenuated Live Vaccine Sales Market Share by Application (2015-2020)
  • Table 43. Global Varicella Attenuated Live Vaccine Sales Growth by Application (2016-2020)
  • Table 44. Merck Corporation Information
  • Table 45. Merck Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2019)
  • Table 46. Merck Varicella Attenuated Live Vaccine Product
  • Table 47. BCHT Corporation Information
  • Table 48. BCHT Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2019)
  • Table 49. BCHT Varicella Attenuated Live Vaccine Product
  • Table 50. Shanghai Institute Corporation Information
  • Table 51. Shanghai Institute Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2019)
  • Table 52. Shanghai Institute Varicella Attenuated Live Vaccine Product
  • Table 53. GSK Corporation Information
  • Table 54. GSK Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2019)
  • Table 55. GSK Varicella Attenuated Live Vaccine Product
  • Table 56. Keygen Corporation Information
  • Table 57. Keygen Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2019)
  • Table 58. Keygen Varicella Attenuated Live Vaccine Product
  • Table 59. Green Cross Corporation Information
  • Table 60. Green Cross Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2019)
  • Table 61. Green Cross Varicella Attenuated Live Vaccine Product
  • Table 62. Biken Corporation Information
  • Table 63. Biken Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2019)
  • Table 64. Biken Varicella Attenuated Live Vaccine Product
  • Table 65. Shanghai Rongsheng Biotech Corporation Information
  • Table 66. Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2019)
  • Table 67. Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccine Product
  • Table 68. Changsheng Corporation Information
  • Table 69. Changsheng Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2019)
  • Table 70. Changsheng Varicella Attenuated Live Vaccine Product
  • Table 71. Production Base and Market Concentration Rate of Raw Material
  • Table 72. Varicella Attenuated Live Vaccine Distributors List
  • Table 73. Varicella Attenuated Live Vaccine Market Trends
  • Table 74. Varicella Attenuated Live Vaccine Opportunities and Drivers
  • Table 75. Varicella Attenuated Live Vaccine Challenges
  • Table 76. Global Varicella Attenuated Live Vaccine Sales Forecast by Type (2021-2026) & (K Doses)
  • Table 77. Global Varicella Attenuated Live Vaccine Sales Market Share Forecast by Type (2021-2026)
  • Table 78. Global Varicella Attenuated Live Vaccine Revenue Forecast by Type (2021-2026) & (US$ Million)
  • Table 79. Global Varicella Attenuated Live Vaccine Revenue Market Share Forecast by Type (2021-2026)
  • Table 80. Global Varicella Attenuated Live Vaccine Sales Forecast by Application (2021-2026) & (K Doses)
  • Table 81. Global Varicella Attenuated Live Vaccine Sales Market Share Forecast by Application (2021-2026)
  • Table 82. Global Varicella Attenuated Live Vaccine Sales Forecast by Region (2021-2026) & (K Doses)
  • Table 83. Global Varicella Attenuated Live Vaccine Sales Market Share Forecast by Region (2021-2026)
  • Table 84. Global Varicella Attenuated Live Vaccine Revenue Forecast by Region (2021-2026) & (US$ Million)
  • Table 85. Global Varicella Attenuated Live Vaccine Revenue Market Share Forecast by Region (2021-2026)
  • Table 86. Research Programs/Design for This Report
  • Table 87. Key Data Information from Secondary Sources
  • Table 88. Key Data Information from Primary Sources
  • Figure 1. Product Picture of Varicella Attenuated Live Vaccine
  • Figure 2. Global Varicella Attenuated Live Vaccine Market Share by Type in 2020
  • Figure 3. Monovalent Vaccine Product Picture
  • Figure 4. Combination Vaccine Product Picture
  • Figure 5. Global Varicella Attenuated Live Vaccine Market Share by Application in 2020
  • Figure 6. Kids Injection
  • Figure 7. Adults Injection
  • Figure 8. Global Varicella Attenuated Live Vaccine Revenue, (US$ Million), 2015 VS 2020 VS 2026
  • Figure 9. Global Varicella Attenuated Live Vaccine Market Size 2015-2026 (US$ Million)
  • Figure 10. Global Varicella Attenuated Live Vaccine Sales 2015-2026 (K Doses)
  • Figure 11. Varicella Attenuated Live Vaccine Sales Share by Manufacturers in 2019
  • Figure 12. Global Varicella Attenuated Live Vaccine Revenue Share by Manufacturers in 2019
  • Figure 13. Figure Global 5 Largest Varicella Attenuated Live Vaccine Players: Market Share by Revenue in Varicella Attenuated Live Vaccine in 2019
  • Figure 14. Global Varicella Attenuated Live Vaccine Sales Market Share by Region in 2019
  • Figure 15. Global Varicella Attenuated Live Vaccine Revenue Market Share by Region in 2019
  • Figure 16. North America Varicella Attenuated Live Vaccine Sales Market Share by Country in 2019
  • Figure 17. U.S. Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) & (US$ Million)
  • Figure 18. Canada Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) & (US$ Million)
  • Figure 19. Germany Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) & (US$ Million)
  • Figure 20. Greece Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) & (US$ Million)
  • Figure 21. Italy Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) & (US$ Million)
  • Figure 22. Spain Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) & (US$ Million)
  • Figure 23. China Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) & (US$ Million)
  • Figure 24. Japan Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) & (US$ Million)
  • Figure 25. South Korea Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) & (US$ Million)
  • Figure 26. Southeast Asia Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) & (US$ Million)
  • Figure 27. Mexico Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) & (US$ Million)
  • Figure 28. Brazil Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) & (US$ Million)
  • Figure 29. Argentina Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) & (US$ Million)
  • Figure 30. Middle East Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) & (US$ Million)
  • Figure 31. Africa Varicella Attenuated Live Vaccine Revenue Growth Rate (2015-2020) & (US$ Million)
  • Figure 32. Sales Market Share of Varicella Attenuated Live Vaccine by Type in 2019
  • Figure 33. Revenue Market Share of Varicella Attenuated Live Vaccine by Type in 2019
  • Figure 34. Sales Market Share of Varicella Attenuated Live Vaccine by Application in 2019
  • Figure 35. Manufacturing Process Analysis of Varicella Attenuated Live Vaccine
  • Figure 36. Varicella Attenuated Live Vaccine Industrial Chain Analysis
  • Figure 37. Channels of Distribution
  • Figure 38. Distributors Profiles
  • Figure 39. Porter's Five Forces Analysis
  • Figure 40. Bottom-up and Top-down Approaches for This Report
  • Figure 41. Data Triangulation
  • Figure 42. Key Executives Interviewed 79

The global Varicella Attenuated Live Vaccine market was valued at US$ 2377.15 million in 2019 and is expected to reach US$ 3152.46 million by the end of 2026, growing at a CAGR of 4.25% during 2020-2026.

This report focuses on Varicella Attenuated Live Vaccine volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Varicella Attenuated Live Vaccine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Mideast & Africa.

Segment Analysis:

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

By Company

  • Merck
  • BCHT
  • Shanghai Institute
  • GSK
  • Keygen
  • Green Cross
  • Biken
  • Shanghai Rongsheng Biotech
  • Changsheng

Segment by Type

  • Monovalent Vaccine
  • Combination Vaccine

Segment by Application

  • Kids Injection
  • Adults Injection

By Region

  • North America
    • U.S.
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • Korea
    • Southeast Asia
    • Europe
    • Germany
    • Italy
    • Greece
    • Spain
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • Middle East
    • Africa

TABLE OF CONTENTS

1 VARICELLA ATTENUATED LIVE VACCINE MARKET OVERVIEW

  • 1.1 Product Overview and Scope of Varicella Attenuated Live Vaccine
  • 1.2 Varicella Attenuated Live Vaccine Segment by Type
    • 1.2.1 Global Varicella Attenuated Live Vaccine Sales Growth Rate Comparison by Type (2020-2026)
    • 1.2.2 Monovalent Vaccine
    • 1.2.3 Combination Vaccine
  • 1.3 Varicella Attenuated Live Vaccine Segment by Application
    • 1.3.1 Global Varicella Attenuated Live Vaccine Sales Comparison by Application (2020-2026)
    • 1.3.2 Kids Injection
    • 1.3.3 Adults Injection
  • 1.4 Global Varicella Attenuated Live Vaccine Market Size Estimates and Forecasts
    • 1.4.1 Global Varicella Attenuated Live Vaccine Revenue 2015-2026
    • 1.4.2 Global Varicella Attenuated Live Vaccine Sales 2015-2026
    • 1.4.3 Varicella Attenuated Live Vaccine Market Size by Region: 2020 Versus 2026

2 VARICELLA ATTENUATED LIVE VACCINE MARKET COMPETITION BY MANUFACTURERS

  • 2.1 Global Varicella Attenuated Live Vaccine Sales Market Share by Manufacturers (2018-2019)
  • 2.2 Global Varicella Attenuated Live Vaccine Revenue Market Share by Manufacturers (2018-2019)
  • 2.3 Global Varicella Attenuated Live Vaccine Average Price by Manufacturers (2018-2019)
  • 2.4 Manufacturers Varicella Attenuated Live Vaccine Headquarters
  • 2.5 Varicella Attenuated Live Vaccine Market Competitive Situation and Trends
    • 2.5.1 Varicella Attenuated Live Vaccine Market Concentration Rate
    • 2.5.2 The Global 5 Largest Varicella Attenuated Live Vaccine Players Market Share by Revenue

3 VARICELLA ATTENUATED LIVE VACCINE RETROSPECTIVE MARKET SCENARIO BY REGION

  • 3.1 Global Varicella Attenuated Live Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
  • 3.2 Global Varicella Attenuated Live Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 3.3 North America Varicella Attenuated Live Vaccine Market Facts & Figures by Country
    • 3.3.1 North America Varicella Attenuated Live Vaccine Sales by Country
    • 3.3.2 North America Varicella Attenuated Live Vaccine Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Varicella Attenuated Live Vaccine Market Facts & Figures by Country
    • 3.4.1 Europe Varicella Attenuated Live Vaccine Sales by Country
    • 3.4.2 Europe Varicella Attenuated Live Vaccine Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 Greece
    • 3.4.5 Italy
    • 3.4.6 Spain
  • 3.5 Asia Pacific Varicella Attenuated Live Vaccine Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Varicella Attenuated Live Vaccine Sales by Region
    • 3.5.2 Asia Pacific Varicella Attenuated Live Vaccine Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 Southeast Asia
  • 3.6 Latin America Varicella Attenuated Live Vaccine Market Facts & Figures by Country
    • 3.6.1 Latin America Varicella Attenuated Live Vaccine Sales by Country
    • 3.6.2 Latin America Varicella Attenuated Live Vaccine Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Varicella Attenuated Live Vaccine Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Varicella Attenuated Live Vaccine Sales by Country
    • 3.7.2 Middle East and Africa Varicella Attenuated Live Vaccine Revenue by Country
    • 3.7.3 Middle East
    • 3.7.4 Africa

4 VARICELLA ATTENUATED LIVE VACCINE HISTORIC MARKET ANALYSIS BY TYPE

  • 4.1 Global Varicella Attenuated Live Vaccine Sales Market Share by Type (2015-2020)
  • 4.2 Global Varicella Attenuated Live Vaccine Revenue Market Share by Type (2015-2020)
  • 4.3 Global Varicella Attenuated Live Vaccine Price by Type (2015-2020)

5 VARICELLA ATTENUATED LIVE VACCINE HISTORIC MARKET ANALYSIS BY APPLICATION

  • 5.1 Global Varicella Attenuated Live Vaccine Sales Market Share by Application (2015-2020)
  • 5.2 Global Varicella Attenuated Live Vaccine Sales Growth by Application (2016-2020)

6 COMPANY PROFILES AND KEY FIGURES IN VARICELLA ATTENUATED LIVE VACCINE BUSINESS

  • 6.1 Merck
    • 6.1.1 Merck Corporation Information
    • 6.1.2 Merck Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2019)
    • 6.1.3 Merck Varicella Attenuated Live Vaccine Products Offered
  • 6.2 BCHT
    • 6.2.1 BCHT Corporation Information
    • 6.2.2 BCHT Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2019)
    • 6.2.3 BCHT Varicella Attenuated Live Vaccine Products Offered
  • 6.3 Shanghai Institute
    • 6.3.1 Shanghai Institute Corporation Information
    • 6.3.2 Shanghai Institute Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2019)
    • 6.3.3 Shanghai Institute Varicella Attenuated Live Vaccine Products Offered
  • 6.4 GSK
    • 6.4.1 GSK Corporation Information
    • 6.4.2 GSK Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2019)
    • 6.4.3 GSK Varicella Attenuated Live Vaccine Products Offered
  • 6.5 Keygen
    • 6.5.1 Keygen Corporation Information
    • 6.5.2 Keygen Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2019)
    • 6.5.3 Keygen Varicella Attenuated Live Vaccine Products Offered
  • 6.6 Green Cross
    • 6.6.1 Green Cross Corporation Information
    • 6.6.2 Green Cross Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2019)
    • 6.6.3 Green Cross Varicella Attenuated Live Vaccine Products Offered
  • 6.7 Biken
    • 6.7.1 Biken Corporation Information
    • 6.7.2 Biken Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2019)
    • 6.7.3 Biken Varicella Attenuated Live Vaccine Products Offered
  • 6.8 Shanghai Rongsheng Biotech
    • 6.8.1 Shanghai Rongsheng Biotech Corporation Information
    • 6.8.2 Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2019)
    • 6.8.3 Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccine Products Offered
  • 6.9 Changsheng
    • 6.9.1 Changsheng Corporation Information
    • 6.9.2 Changsheng Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2019)
    • 6.9.3 Changsheng Varicella Attenuated Live Vaccine Products Offered

7 VARICELLA ATTENUATED LIVE VACCINE MANUFACTURING COST ANALYSIS

  • 7.1 Varicella Attenuated Live Vaccine Key Raw Materials Analysis
  • 7.2 Manufacturing Process Analysis of Varicella Attenuated Live Vaccine
  • 7.3 Varicella Attenuated Live Vaccine Industrial Chain Analysis

8 MARKETING CHANNEL AND DISTRIBUTORS

  • 8.1 Marketing Channel
  • 8.2 Varicella Attenuated Live Vaccine Distributors List

9 VARICELLA ATTENUATED LIVE VACCINE MARKET DYNAMICS

  • 9.1 Varicella Attenuated Live Vaccine Market Trends
  • 9.2 Varicella Attenuated Live Vaccine Opportunities and Drivers
  • 9.3 Varicella Attenuated Live Vaccine Challenges
  • 9.4 Porter's Five Forces Analysis

10 GLOBAL MARKET FORECAST

  • 10.1 Varicella Attenuated Live Vaccine Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Varicella Attenuated Live Vaccine by Type (2021-2026)
    • 10.1.2 Global Forecasted Revenue of Varicella Attenuated Live Vaccine by Type (2021-2026)
  • 10.2 Varicella Attenuated Live Vaccine Market Estimates and Projections by Application
  • 10.3 Varicella Attenuated Live Vaccine Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Varicella Attenuated Live Vaccine by Region (2021-2026)
    • 10.3.2 Global Forecasted Revenue of Varicella Attenuated Live Vaccine by Region (2021-2026)

11 RESEARCH FINDINGS AND CONCLUSION

12 METHODOLOGY AND DATA SOURCE

  • 12.1 Methodology/Research Approach
    • 12.1.1 Research Programs/Design
    • 12.1.2 Market Size Estimation
    • 12.1.3 Market Breakdown and Data Triangulation
  • 12.2 Data Source
    • 12.2.1 Secondary Sources
    • 12.2.2 Primary Sources
  • 12.3 Author List
  • 12.4 Disclaimer
Back to Top
전화 문의
F A Q